- Home
- ATPC vs HEPA Comparison
ATPC vs HEPA Comparison
Compare ATPC & HEPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATPC
- HEPA
- Stock Information
- Founded
- ATPC 2016
- HEPA 2013
- Country
- ATPC Malaysia
- HEPA United States
- Employees
- ATPC N/A
- HEPA N/A
- Industry
- ATPC Medical/Nursing Services
- HEPA Biotechnology: Pharmaceutical Preparations
- Sector
- ATPC Health Care
- HEPA Health Care
- Exchange
- ATPC Nasdaq
- HEPA Nasdaq
- Market Cap
- ATPC 4.6M
- HEPA 4.1M
- IPO Year
- ATPC N/A
- HEPA N/A
- Fundamental
- Price
- ATPC $1.33
- HEPA $0.47
- Analyst Decision
- ATPC
- HEPA
- Analyst Count
- ATPC 0
- HEPA 0
- Target Price
- ATPC N/A
- HEPA N/A
- AVG Volume (30 Days)
- ATPC 4.6M
- HEPA 100.9K
- Earning Date
- ATPC 02-15-2025
- HEPA 11-14-2024
- Dividend Yield
- ATPC N/A
- HEPA N/A
- EPS Growth
- ATPC N/A
- HEPA N/A
- EPS
- ATPC N/A
- HEPA N/A
- Revenue
- ATPC $1,354,042.00
- HEPA N/A
- Revenue This Year
- ATPC N/A
- HEPA N/A
- Revenue Next Year
- ATPC N/A
- HEPA N/A
- P/E Ratio
- ATPC N/A
- HEPA N/A
- Revenue Growth
- ATPC N/A
- HEPA N/A
- 52 Week Low
- ATPC $1.07
- HEPA $0.43
- 52 Week High
- ATPC $19.60
- HEPA $3.49
- Technical
- Relative Strength Index (RSI)
- ATPC 49.56
- HEPA 42.44
- Support Level
- ATPC $1.26
- HEPA $0.43
- Resistance Level
- ATPC $2.93
- HEPA $0.53
- Average True Range (ATR)
- ATPC 0.19
- HEPA 0.07
- MACD
- ATPC 0.02
- HEPA -0.01
- Stochastic Oscillator
- ATPC 14.02
- HEPA 13.36
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.
About HEPA Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.